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1. Introduction 
A short cold ischemic time, an optimal HLA match and other pre-transplant factors are in a 
key role in the success of kidney transplantation. Over the past decades, the acute rejection 
rate of kidney transplants has fallen dramatically and the 1-year graft survival rate has 
increased to 90% in transplantations with deceased donors and 95% with living related 
donors. This increase in graft survival is largely due to advances in immunosuppressant 
medication (Yates & Nicholson, 2006). But, due to undesired side effects usually associated 
with immunosuppressive regimens, reduced immunosuppression is warranted whenever 
possible. 
Acute rejection has been the most common end point of genetic association studies. This is 
natural as acute rejection predicts decreased long-term allograft survival. Despite progress 
in immunosuppression, the long-term graft survival has not increased in patients suffering 
acute rejection episodes (Meier-Kriesche et al., 2004). In many genetic studies, chronic 
allograft nephropathy and subsequent graft loss have been the endpoints with which 
genetic variation has been compared. 
1.1 Genetic polymorphisms affect on outcome of kidney transplantation 
Although human leukocyte antigen (HLA) genes are the major genetic factors in the 
immunological acceptance of the graft, also other, non-HLA gene variants may predict 
outcome of kidney transplantation. Identification of genetic factors determining, for 
example, the strength of immunological response against the graft, or metabolism or side 
effects of drugs, could lead to more accurate risk assessments or more tailored 
immunosupressive regimens for patients. 
1.1.1 Immune genes are interesting candidates 
Immune genes, i.e. the genes encoding for molecules regulating or affecting immune 
responses, are involved in the etiopathology of autoimmune diseases and probably also in the 
outcome of organ transplantation. Polymorphisms in immune genes may induce functional or 
quantitative differences in immune responsiveness between patients, resulting in for example 
high and low cytokine producers. Single nucleotide polymorphisms (SNPs) can have an effect 
on gene expression, not only the SNPs located in exons, possibly changing amino acids, or in 
promoter regions, possibly changing the crucial regulatory sequences, but also polymorphisms 
in introns have been shown to be of importance in genetic susceptibility studies. Thus, 
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although functional variants are the most relevant to study, all polymorphisms are potentially 
interesting. Immune genes encode, for example, cytokines, chemokines, growth factors and T 
cell co-activation molecules. 
1.1.2 Cytokines are major regulators of the immune response 
Most genetic association studies in kidney transplantation have focussed on the genes 
encoding cytokines. Variations in the cytokine genes may lead to differences in the levels of 
their production or signalling, which in turn may modulate the strength of the immune 
response. Thus, they are potential candidate genes related to organ transplantation as they 
may predict the overall immunological responsiveness of the patient toward the graft. 
Cytokines can be classified on the basis of their function to the pro-inflammatory cytokines, 
such as tumor necrosis factor (TNF), interleukin (IL)1┚, interferon (IFN) ┛, IL6, IL12, IL17 and 
IL18, and to the anti-inflammatory cytokines, including IL4, IL10, IL13, IFN┙ and transforming 
growth factor (TGF) ┚. However, it is of note that the effect of any single cytokine may depend 
on the exact environment it is acting in. The balance between pro- and anti-inflammatory 
cytokines partially determines the level or strength of the immune response (Dinarello, 1997). 
Below, we present a few examples from the wide variety of cytokines. 
1.1.2.1 Tumor necrosis factor 
Perhaps the most actively studied cytokine in genetic studies is the tumor necrosis factor 
(TNF), which has multiple roles in innate immunity, apoptosis and metabolism. TNF 
stimulates neutrophil and macrophage function and is a key mediator of inflammation. 
Production of TNF leads to massive inflammatory reactions in response to several 
immunological challenges (Hehlgans & Pfeffer, 2005). TNF and its receptors could be useful 
biomarkers for organ rejection, as TNF is not detectable in healthy individuals, but elevated 
serum levels are found in kidney transplant recipients (Maury & Teppo, 1987). 
The TNF gene is located on chromosome 6 in the HLA class III region and is in linkage 
disequilibrium with classical HLA genes (Low et al., 2002). The -308G>A promoter variant of 
the TNF gene influences the expression of the TNF protein (Abraham & Kroeger, 1999). 
1.1.2.2 Transforming growth factor ┚ 1 
Mammals have three isoforms of transforming growth factor ┚ (TGF┚-1, TGF┚-2 and TGF┚-
3) (Derynck et al., 1985). TGF┚-1 is the most abundant and most studied of the isoforms. It is 
a strong anti-inflammatory cytokine that regulates proliferation, apoptosis and 
differentiation of many cell types. TGF┚-1 affects T cell survival and Th differentiation for 
example regulating the development of effector cells and induction of Treg cells (Rubtsov & 
Rudensky, 2007). TGF┚-1 activates a profibrotic process and its increased expression has 
been associated with chronic rejection (Campistol et al., 2001). 
The TGFB1 gene lies on the chromosome region 19q13.2 and encodes a protein of 390 amino 
acids. A few polymorphisms have been identified in the gene and three of them (Leu10Pro, 
Arg25Pro and Thr263Ile) change an amino acid.  
1.1.2.3 Interleukin 10 
Interleukin 10 (IL10) promotes the Th2-type immune response and B-cell mediated 
functions leading to antibody production. Besides, it inhibits the Th1-type immune response 
by suppressing the expression of proinflammatory cytokines, hence being anti-
inflammatory. IL10 also inhibits antigen presenting cells by downregulating the expression 
of HLA class II molecules (Ding et al., 1993). 
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The IL10 gene, located in 1q32.2, is 4892 bases long and encodes a protein of 178 amino 
acids. There are several polymorphisms in the promoter region of IL10; they are in strong 
linkage disequilibrium (Turner et al., 1997) and thus, form haplotypes (Lin et al., 2003). 
1.1.2.4 Interferon ┛ 
IFN┛ is a proinflammatory cytokine produced by activated T cells. IFN┛ has several roles in 
the immune response: it activates macrophages, mediates the lytic effect, potentiates the 
actions of other interferons and it also inhibits intracellular microorganisms other than 
viruses (Dianzani & Baron, 1996). IFN┛ acts both as an anti-rejection and pro-rejection 
cytokine, e.g. by inducing microvascularisation in the grafted organ and up-regulating the 
expression of HLA molecules. The predominant effect mainly depends on the secretion time 
after transplantation, being protective early on and then later becoming antagonistic 
(Hidalgo & Halloran, 2002). 
The IFNG gene lies in 12q15 and encodes a protein of 166 amino acids. The most studied 
IFNG polymorphisms are the SNP +874T>A in the intron 1 and the short tandem repeat CA 
(rs3138557). These have been associated with acute rejection and chronic allograft 
nephropathy. 
1.1.3 Co-stimulatory receptors mediate T cell activation 
Besides cytokine genes, another interesting gene group is those coding for T cell co-
stimulatory receptors. Co-stimulatory signals are essential for the activation of naïve T cells 
and productive immune response. For activation, naïve T cells must receive an antigen-
specific signal through the T cell receptor and additionally a signal by co-stimulatory 
receptors. Without the co-stimulatory signal the T cell turns anergic. In addition, the co-
stimulatory signal can be negative, that is, inhibitory after the initial activation. The fine 
balance between the positive and negative signals determines the outcome of an immune 
response. 
1.1.3.1 CD28 is an essential co-stimulator 
The CD28 pathway is crucial for T cell activation; signalling through CD28 increases 
cytokine production in T cells, by enhancing transcriptional activity and stabilizing 
messenger RNA (Thompson et al., 1989). CD28 ligation also reduces the number of engaged 
TCRs that are needed for proliferation or effective cytokine production, thereby lowering 
the threshold for T cell activation (Viola & Lanzavecchia, 1996). CD28 is expressed 
constitutively on T cells and it binds to ligands B7-1 (CD80) and B7-2 (CD86) found 
primarily on antigen presenting cells. These ligands have distinct but overlapping functions; 
B7-2 may mediate initial T cell activation, while B7-1 may be more important for 
maintaining the immune response (Vincenti & Luggen, 2007). Antigen specific signal 
without CD28 mediated signal turns T cells anergic. 
Located on chromosome 2q33, the CD28 gene was identified in the late 1980s (Aruffo & 
Seed, 1987). The gene contains one microsatellite and at least 50 SNPs, which, however but 
they are not associated with organ transplantation. 
1.1.3.2 CTLA4 has an inhibitory function 
Cytotoxic T lymphocyte associated antigen 4 (CTLA4) mediates a critical inhibitory signal 
for T cell activation. CTLA4 binds with higher affinity, to the same B7 ligands as CD28. It is 
induced on T cells after their activation, and functions in the downregulation of T cell 
www.intechopen.com
  
Kidney Transplantation – New Perspectives 
 
294 
activation; CTLA4 ligation raises the activation threshold for T cells. CTLA4 decreases 
interleukin 2 (IL2) and IL2 receptor expression and arrests T cells at the G1 phase of the cell 
cycle (Vincenti & Luggen, 2007). The CTLA4 pathway may have an important role in 
peripheral T cell tolerance (Yamada et al., 2002). Principal evidence for an inhibitory 
function of CTLA4 was obtained from CTLA4 knockout mice. These CTLA4 deficient 
(CTLA4-/-) mice develop a fatal lymphoproliferative disorder with multiorgan autoimmune 
disease (Tivol et al., 1995; Waterhouse et al., 1995). 
CTLA4 is located adjacent to CD28. CTLA4 includes one microsatellite and four SNPs, of 
which +49A/G is in a coding region and leads to a change of amino acid (Ala-Thr). 
Genetic variation in CTLA4 is associated with several autoimmune diseases including 
coeliac disease, type 1 diabetes, autoimmune hypothyroidism and Grave’s disease (Duffy, 
2007). 
 1.1.3.3 ICOS induces cytokine expression 
Inducible co-stimulator (ICOS) plays a critical, independent role in T cell activation, in a 
manner that is synergistic with CD28 signalling. ICOS augments effector T cell cytokine 
responses; in particular, it appears to superinduce production of the anti-inflammatory 
cytokine IL10 (Hutloff et al., 1999). ICOS expression is enhanced on activated T cells by 
CD28 co-stimulation (Beier et al., 2000). ICOS binds B7 related protein 1, (B7RP-1) which is 
expressed constitutively by B cells and macrophages (Yoshinaga et al., 1999) but can also be 
induced on non-lymphoid cells by inflammatory stimuli (Swallow et al., 1999). ICOS 
knockout mice have reduced CD4+ T cell responses (Dong et al., 2001) as well as defects in 
immunoglobulin (Ig) class switching (McAdam et al., 2001). 
ICOS is located in very close proximity to CD28 and CTLA4 on the 2q33 region (Hutloff et 
al., 1999). The remarkable homology (over 20 %) between the costimulatory receptor genes 
(Harper et al., 1991; Ling et al., 1999) strongly suggests that the genes belong to the same 
gene family, which is the result of gene duplications. ICOS contains two microsatellites in 
intron 4 and over 30 SNPs, but so far it has been included in only one genetic association 
study on solid organ transplantation. 
 1.1.3.4 Therapeutic potential of co-stimulatory receptors 
Blockade of the CD28 co-stimulatory pathway provides a promising therapeutic strategy for 
transplantation. CTLA4-Ig is a fusion protein which consists of the extracellular binding 
domain of CTLA4 linked to a modified Fc domain of human antibody IgG. The Fc domain 
mediates complement activation and interacts with Fc cell surface receptors. The CTLA4 
fragment defines the specific targets of the fusion antibody, which are the B7 ligands. It was 
developed to selectively interrupt full T cell activation by blocking the interaction of CD28 
and B7 ligands (Vincenti & Luggen, 2007). The use of CTLA4-Ig is effective in inducing long-
term allograft survival in solid organ transplantation in mouse, rat and primate models 
(Snanoudj et al., 2006). The first clinical trial with CTLA4-Ig in human renal transplantation 
showed promise although immunosuppressive drug cyclosporine was still more effective in 
preventing acute rejection (Vincenti, 2005). 
The impact of the ICOS co-stimulation pathway on emerging rejection episodes has been 
demonstrated by anti-ICOS therapy (Özkaynak et al., 2001). Anti-ICOS antibody treatment 
has also been studied together with anti-CD40L and CTLA4-Ig in animal models of 
transplantation; the animals displayed fewer signs of chronic rejection (Snanoudj et al., 
2006). 
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2. Accumulated literature of immune gene studies 
In this review, we aim to examine all the published association studies of potential 
candidate genes of cytokines and co-stimulatory receptors. We did a systematic search for 
literature in the PubMed database (National Library of Medicine, Bethesda, MD, US; 
www.ncbi.nlm.nih.gov/pubmed). We used search terms renal transplant, renal 
transplantation, kidney transplant or kidney transplantation and gene*, polymorphism or 
SNP. Literature addressing genetic association studies related to cytokines and co-
stimulatory receptors was selected. Articles not reported in English were excluded; 
otherwise no limitations were set on the publishing manner.  
3. Results 
We found 85 original articles which are listed in Tables 1 and 2. Most genetic association 
studies in kidney transplantation focus on cytokine genes. Despite the number of reported 
positive associations with cytokine genes, the results are confusing because different studies 
report differing variants as demonstrating the strongest association. All the genetic 
associations are listed in the Tables 1 and 2 as they have been published although most of 
them are just nominally significant, and only in a few studies, the correction for multiple 
testing is performed appropriately. 
3.1 Cytokine genes associate with poor outcome of kidney transplantation 
The TNF gene is one of the most frequently studied cytokine genes and variation in this 
gene has been shown to have functional effects (Wilson et al., 1997). The most interesting -
308 variant of the gene has a potential functional effect, being associated with elevated TNF 
levels (Elahi et al., 2009). One of the first large genetic association studies containing 
cytokine gene polymorphisms was done by Mytilineos et al (2004). A total of 2,298 first and 
1,901 repeat kidney recipients were included in the study involving 73 transplant centres. 
An association was found between the high TNF producer genotype -308A and lower graft 
survival (P=0.0116 after Bonferroni correction) in retransplant patients (Mytilineos et al., 
2004). Other parameters than graft survival were not analysed due to difficulties in getting 
standardized clinical variables from different centres in the retrospective study. The TNF 
gene, albeit in organ donors, is also associated with acute rejection  (Alakulppi et al., 2004; 
Lee et al., 2004) and delayed graft function (Israni et al., 2008). In a relatively large study by 
Israni et al (2008), in addition to 965 kidney recipients, also 512 deceased donors were 
genotyped. The G allele of TNF +851 in donors was found to be associated with delayed 
graft function (Israni et al., 2008). 
The variants of the IL10 gene have been reported to be associated with acute rejection either 
by increasing risk or by being protective, depending on the polymorphism and related 
genotype. The haplotypes containing the promoter region SNPs -1082A>G, -819C>T and 
-592C>A have been reported to correlate with IL10 production, leading to high 
(GCC/GCC), intermediate (GCC/ACC or GCC/ATA) and low producers (ATA/ATA) 
(Koss et al., 2000). In a meta-analysis, combining the data of 1,087 patients from eight 
studies, a suggestive association was found between a poor outcome (meaning graft failure, 
acute or chronic rejection and chronic allograft nephropathy) and the IL10 haplotype -
1082A, -819C, -592C (Thakkinstian et al., 2008). The number of cases was high 
(approximately 300 depending on genetic variant analysed) but the authors had to accept 
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compromises while pooling the data, which may be the reason for the insufficient power in 
statistical tests. 
A total of 237 kidney transplantation patients were included in a multicentre study by 
Grinyo et al (2008), in which associations were found between the IL10 and TNF gene 
polymorphisms (P=0.024 and 0.03) and acute rejection (Grinyo et al., 2008). The results were 
not corrected for multiple testing and would not have been statistically significant after 
correction. A sufficient number of infrequent genotypes and acute rejection episodes could 
not be found among 237 patients and thus, some of the groups compared were too small to 
give adequate power for analysis. The same cytokine genes, IL10 and TNF, were reported to 
associate with cardiovascular disease after renal transplantation in a cohort of 798 of Italian 
patients (La Manna et al., 2010). On the other hand, a Czech single centre study did not 
confirm the association with TNF, TGFB1 or IFNG although the authors had collected 
samples of 436 kidney recipients, of whom 122 had chronic allograft nephropathy and 190 
had acute rejection (Brabcova et al., 2007).  
In a recent study by Israni et al (2010), altogether 2,724 SNPs were genotyped in a total of 
990 kidney recipients. They found several SNPs to be associated with acute rejection and its 
severity, among them a polymorphism in the gene of the cytokine IL15 receptor. An 
interesting finding to arise from this multicentre study was the significant difference 
(P<0.0001) in rates of acute rejection (0-30%) between different transplantation centres. The 
data was stratified by centres, thus associations were not masked by the centre to centre 
variation. This stratification could also be recommended for other multicentre studies. The 
authors speculated that the variation between transplantation centres can explain why 
associations are so difficult to repeat in other patient cohorts from different transplantation 
centres (Israni et al., 2010).  
3.2 Co-stimulator receptor genes may predispose to the poor outcome of 
transplantation 
Two of the genetic variants of CD28 were included in three different association studies but 
no association was found (Haimila et al., 2009b; Krichen et al., 2009; Kusztal et al., 2010). 
CTLA4 gene polymorphisms have been examined in relation to kidney transplantation in a 
few studies (Table2). An association with outcome of kidney transplantation was reported in 
seven genetic studies (Slavcheva et al., 2001; Gendzekhadze et al., 2006; Wisniewski et al., 
2006; Gorgi et al., 2006; Kusztal et al., 2007, 2010; Kim et al., 2010). On the other hand, four 
studies did not succeed in replicating the association with CTLA4 (Dmitrienko et al., 2005; 
Haimila et al., 2009b; Krichen et al., 2009, 2010). The SNP CTLA4+49 A/G (rs231775) is the 
most frequently studied variant and most often found to be associated. For example Kim et 
al studied 325 Korean renal patients for a haplotype of three CTLA4 markers and reported 
an association (P=0.039 after Bonferroni correction) with late acute rejection (Kim et al., 
2010). The microsatellite CTLA4(AT)n was included in two studies, both reporting an 
association (Slavcheva et al., 2001; Kusztal et al., 2010). A high number of AT repeats 
predisposed to acute rejection (Slavcheva et al., 2001) and decreased long-term allograft 
function (Kusztal et al., 2010). 
Variants of the ICOS gene are found to predispose to the delayed graft function and the 
decreased graft survival in kidney transplantation patients (Haimila et al., 2009b). A total of 
678 kidney transplantation patients, all from a single transplantation centre, were genotyped 
for 13 markers across the whole CD28-CTLA4-ICOS gene region. A statistically significant 
association between the ICOS marker rs10932037 and graft survival (P= 0.026) was found, in 
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addition to an association with delayed functioning or non-functioning, of the graft with the 
ICOS markers rs10183087 and rs4404254 (P=0.020, OR=5.8 and P=0.019, OR=5.8). This is to 
date the only study to examine the association of the ICOS gene in relation to kidney 
transplantation. 
The distance between the genetic markers used and the actual risk factor may be long due to 
the strong LD in the region (Holopainen & Partanen, 2001). A thorough examination of 
polymorphisms within the 2q33 region is necessary for the reliable identification of the 
primary variant. The association analyses of the published co-stimulator gene studies are 
solely limited to a few markers in the CTLA4 gene, unfortunately leaving out the 
neighbouring ICOS and CD28 genes. In our previous study, we examined genetic markers 
through the entire chromosome region and the results suggested that ICOS, rather than 
CTLA4, is the genetic factor affecting the outcome of kidney transplantation (Haimila et al., 
2009b). 
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Gene 
polymorphism 
dbSNP  
rs number 
Citation  
Association 
Citation  
No association 
IL10 -851C>T rs1800894  Grinyo et al., 2008 
IL10 
+4259A>G 
rs3024498  donor: Israni et al., 2008 
IL10 +434C>T rs2222202  donor: Israni et al., 2008 
IL10 IVS3-
112A>G 
rs3024494  donor: Israni et al., 2008 
IL10 IVS3-
474C>G 
rs1878672  donor: Israni et al., 2008 
IL10 
gIVS3+284G>T 
rs3024493  donor: Israni et al., 2008 
IL10 
IVS3+19T>C 
rs1554286  donor: Israni et al., 2008 
IL10 IVS1-
192A>C 
rs3021094  donor: Israni et al., 2008 
IL6 -174G>C rs1800795 Hahn et al., 2001; Reviron et 
al., 2001; Muller-Steinhardt 
et al., 2002; Lacha et al., 
2005; Nikolova et al., 2008; 
Pawlik et al., 2008; Kocierz 
et al., 2011;  
donor: Marshall et al., 2001; 
Ligeiro et al., 2004; Canossi 
et al., 2007; Nikolova et al., 
2008  
Cartwright et al., 2000; 
Cartwright et al., 2001; Marshall 
et al., 2001; Hutchings et al., 
2002; McDaniel et al., 2003; 
Ligeiro et al., 2004; Uboldi de 
Capei et al., 2004;Alakulppi et 
al., 2004; Hoffmann et al., 2004; 
Loucaidou et al., 2005; Tinckam 
et al., 2005; Gendzekhadze et al., 
2006; ; Coppo et al., 2007; 
Breulmann et al., 2007; Satoh et 
al., 2007; Rodrigo et al., 2007;  
Alakulppi et al., 2008; 
Manchanda et al., 2008; 
Manchanda & Mittal; 2008; 
Grenda et al., 2009; Martin et al., 
2009; Kruger et al., 2009; 
Lobashevsky et al., 2009; Khan et 
al., 2010; Jacobson et al., 2010; 
Sanchez-Velasco et al., 2010; La 
Manna et al., 2010; Israni et al., 
2010;  
donor: Alakulppi et al., 2004; 
Loucaidou et al., 2005; Lacha et 
al., 2005; Manchanda & Mittal, 
2008; Martin et al., 2009; 
Krajewska et al., 2009  
IL6 +565>A rs1800797  Rodrigo et al., 2007; 
Lobashevsky et al., 2009  
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Gene 
polymorphism 
dbSNP  
rs number 
Citation  
Association 
Citation  
No association 
IL6 +1888G>T rs1554606  Kruger et al., 2009 
IL6 Pro32Ser rs2069830  Kruger et al., 2009 
IL6 Asp162Val rs2069860  Kruger et al., 2009 
IFNG 
+874T>A 
rs2430561 McDaniel et al., 2003; 
Tinckam et al., 2005; 
Mendoza-Carrera et al., 
2008; Nikolova et al., 2008; 
Lobashevsky et al., 2009; 
Zibar et al., 2011; donor: 
Hoffmann et al., 2004; 
Canossi et al., 2007; 
Nikolova et al., 2008  
Hahn et al., 2001; Hutchings et 
al., 2002; Muller-Steinhardt et al., 
2002; Ligeiro et al., 2004; 
Alakulppi et al., 2004; Uboldi de 
Capei et al., 2004; Azarpira et al., 
2006; Gendzekhadze et al., 2006; 
Brabcova et al., 2007; Coppo et 
al., 2007; Rodrigo et al., 2007; 
Satoh et al., 2007; Azarpira et al., 
2009; Singh et al., 2009; Khan et 
al., 2010; Omrani et al., 2010; 
Crispim et al., 2010; La Manna et 
al., 2010; Kocierz et al., 2011;   
donor: Alakulppi et al., 2004; 
Ligeiro et al., 2004; Mendoza-
Carrera et al., 2008; Azarpira et 
al., 2009  
IFNG (CA)n rs2234688 Mendoza-Carrera et al., 2008 donor: Mendoza-Carrera et al., 
2008 
IL1A -889T>C rs1800587 Jin & Ruiz, 2008;  
donor: Jin & Ruiz, 2008 
Rodrigo et al., 2007; 
Lobashevsky et al., 2009; Khan et 
al., 2010  
IL1B -31C>T rs1143627  Grenda et al., 2009 
IL1B -511C>T rs16944 Rodrigo et al., 2007, Jin & 
Ruiz, 2008; donor: Jin & 
Ruiz, 2008 
Manchanda & Mittal, 2008; Khan 
et al., 2010; donor: Manchanda & 
Mittal, 2008 
IL1B 
+3962C>T 
rs1143634 Manchanda & Mittal, 2008; 
Jin & Ruiz, 2008; 
donor: Jin & Ruiz, 2008 
Rodrigo et al., 2007; Manchanda 
& Mittal, 2008; Lobashevsky et 
al., 2009; Khan et al., 2010;  
donor: Manchanda & Mittal, 
2008; Krajewska et al., 2009; 
Khan et al., 2010  
IL1R 
+1970C>T 
rs2234650  Rodrigo et al., 2007; 
Lobashevsky et al., 2009   
IL1RA +11100 
T>C 
rs315952  Rodrigo et al., 2007; 
Lobashevsky et al., 2009; Khan et 
al., 2010,  
IL1RN VNTR rs2234663 Jin & Ruiz, 2008; donor: Jin 
& Ruiz, 2008 
Manchanda & Mittal, 2008; 
Grenda et al., 2009; donor: 
Manchanda & Mittal, 2008  
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polymorphism 
dbSNP  
rs number 
Citation  
Association 
Citation  
No association 
IL2 -330T>G rs2069762 Satoh et al., 2007 Rodrigo et al., 2007; Grinyo et al., 
2008; Manchanda et al., 2008; 
Manchanda & Mittal, 2008; 
Pawlik et al., 2008; Lobashevsky 
et al., 2009; donor: Manchanda & 
Mittal, 2008 
IL2 +166G>T rs2069763  Rodrigo et al., 2007; Grinyo et al., 
2008; Lobashevsky et al., 2009   
IL3 +132C>T rs40401 Lee et al., 2010  
IL3 -1107G>A rs181781 Lee et al., 2010  
IL3 -1484G>A rs2073506 Lee et al., 2010  
IL4 VNTR 
intron 3 
rs8179190 Manchanda et al., 2008 Manchanda & Mittal, 2008;  
donor: Manchanda & Mittal, 
2008 
IL4 -1098T>G rs2243248  Rodrigo et al., 2007; 
Lobashevsky et al., 2009  
IL4 -590T>C rs2243250  Rodrigo et al., 2007, Satoh et al., 
2007; Pawlik et al., 2008; 
Lobashevsky et al., 2009 
IL4 -33T>C rs2070874  Rodrigo et al., 2007; 
Lobashevsky et al., 2009   
IL4R 
+1902G>A 
rs1801275 Lobashevsky et al., 2009 Rodrigo et al., 2007 
IL8 -251A>T rs4073 Singh et al., 2009 La Manna et al., 2010; Ro et al., 
2010;  
donor: Ro et al., 2010 
IL12 -1188C>A rs3212227 Rodrigo et al., 2007; 
Hoffmann et al., 2008; 
Lobashevsky et al., 2009 
 
IL12A 
+8685G>A 
rs568408 Jacobson et al., 2010 Israni et al., 2010 
IL12B -
1188C>A 
rs3212227  Kolesar et al., 2007; Satoh et al., 
2007; Chin et al., 2008; Khan et 
al., 2010 
IL18 -137G>C rs187238 Kim et al., 2008; Mittal et al., 
2011 
donor: Mittal et al., 2011 
IL18 –607A>C rs1946518 Kolesar et al., 2007 Mittal et al., 2011; donor: Mittal 
et al., 2011 
IL23R 
+2199A>C 
rs10889677 Tsai et al., 2011  
 
Table 1. All the published genetic association studies related to cytokines listed according to 
the polymorphisms examined. 
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3.3 Kidney transplantation is a challenging study subject 
During the last decade, a number of genetic association studies focusing on the outcome in 
kidney transplantation have been published. The results as a whole are contradictory and 
the effect of genetic variation on the outcome of transplantation still requires confirmation. It 
might be that the results of genetic studies are not reproduced due to a high level of genetic 
and environmental heterogeneity, both certainly relevant in kidney transplantation. There is 
growing evidence that certain genes or gene loci, such as CTLA4–CD28–ICOS cluster, 
regulate the immune response as their variation is associated with both susceptibility to 
autoimmunity and the outcome of transplantation. However, the same genes may also 
indirectly predispose to the underlying disease and its progression, or to the need for 
transplantation. Non-genetic, confounding factors are numerous: the original disease 
causing the need for kidney replacement, donor matching, surgical aspects, condition of the 
donor organ prior to transplantation etc. Besides, immunosuppressive drugs are highly 
effective and their administration can mask the genetic effect on the variance in immune 
response. Furthermore, it is essential to consider the effects of immunosuppressive drugs: 
gene variants regulating e.g. T cell response may not be detectable in patients receiving 
immunosuppressants affecting the T cell response. 
As the current immunosuppressive regimens are very effective, the patients who still 
develop rejection, or some other complication, can be assumed to belong to the extreme 
high-responder end of patients. In genetic analysis this can be regarded as strength -we 
know we are studying the patients with a very strong tendency to develop immunological 
problems in kidney transplantation.  
The problems related to the environmental factors can be reduced by a careful study design, 
such as attention to the precise definition of outcome phenotypes. Recruitment of sufficient 
numbers of patients would naturally improve the quality of studies. Prospective studies, if 
possible in a single centre single-centre would also be preferable, as many environmental 
factors could then be controllable but the number of cases available may remain relatively 
modest. Most studies have focused on allograft recipients, but evaluating also donors or 
even donor-recipient pairs, would give a new point of view. 
Genetic variants should be carefully chosen instead of settling for a few most studied single 
nucleotide polymorphisms. Strong linkage disequilibrium (LD) influences association 
studies. It is currently assumed that our chromosomes are composed of haplotypic blocks 
that are relatively well conserved, in other words the genetic markers are said to be in 
linkage disequilibrium with each other. LD may help genetic studies as certain informative 
markers can be used as tags for a preliminary screening of haplotype blocks. On the other 
hand, the conserved structure of the blocks may be a hurdle in pinpointing the actual 
causative polymorphism. Exceptionally strong LD throughout the HLA region is well 
known. This fact also affects the interpretation of the role of TNF as it is located within the 
HLA block and hence HLA compatibility or matching leads to TNF matching as well. There 
is also strong LD on the 2q33 region (Holopainen & Partanen, 2001); not only within co-
stimulatory receptor genes but also between them. CD28 and the 5’end of ICOS exist in their 
own LD blocks, and between them, CTLA4 and the 3’ part of ICOS are within the same LD 
block (Ueda et al., 2003). Conservative haplotypes containing variants of both CTLA4 and 
ICOS genes are found (Haimila et al., 2009a) and thus, the haplotypes must be taken in 
consideration when making conclusions from association results. Once good candidate 
polymorphisms with detectable and confirmed genetic effects are found, it is essential to 
start looking for functional differences. This has turned out to be problematic but not 
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impossible. For example certain genetic variations in the CTLA4–CD28-ICOS cluster appear 
to affect the gene expression level or change the alternative splicing preferences of the genes 
(Ueda et al., 2003; Kaartinen et al., 2007). 
More complex statistical analyses of many genetic and environmental variants 
simultaneously are required to test joint contributions to the risk and adjustment for 
potential confounders. Multivariate analyses have more power to detect minor impacts of 
single variables. Besides, correction of multiple comparisons is required due to a high 
probability of false positives (type 1 error) when several polymorphisms related to several 
outcomes are tested. A particular statistical challenge in the transplantation settings, which 
has not been tackled so far, is the fact that we are studying donor – recipient pairs instead of 
merely patients versus non-affected. 
 
Gene 
polymorphism 
dbSNP   
rs number 
Citation  
Association 
Citation  
No association 
CD28-594A>G rs35593994  Haimila et al., 2009b 
CD28ivs3+17C
>T 
rs3116496     Krichen et al., 2010; Kusztal et 
al., 2010 
CTLA4-
1722A>G 
rs733618  Gendzekhadze et al., 2006 
CTLA4-
1661G>A 
rs553808  Gendzekhadze et al., 2006; 
Haimila et al., 2009b  
CTLA4-
1147C>T 
rs16840252  Wisniewski et al., 2006; Kim et 
al., 2010  
CTLA4-318C>T rs5742909 Wisniewski et al., 2006; 
Gorgi et al., 2006; Kusztal 
et al., 2007  
Dmitrienko et al., 2005; 
Gendzekhadze et al., 2006; 
Haimila et al., 2009b; Kim et 
al., 2010; Kusztal et al., 2010  
CTLA4+49A>G rs231775 Gendzekhadze et al., 2006; 
Gorgi et al., 2006; Kusztal 
et al., 2007;  Kim et al., 
2010; Kusztal et al., 2010 
Slavcheva et al., 2001; 
Dmitrienko et al., 2005;  
Wisniewski et al., 2006; 
Haimila et al., 2009b  
CTLA4(AT)n   Slavcheva et al., 2001; 
Kusztal et al., 2010  
Krichen et al., 2010 
CT60G>A rs3087243  Haimila et al., 2009b 
ICOSivs+173T>
C 
rs10932029  Haimila et al., 2009b 
ICOSc602A>C rs10183087 Haimila et al., 2009b  
ICOSc1564C>T rs4404254 Haimila et al., 2009b  
ICOSc1624C>T rs10932037 Haimila et al., 2009b  
ICOSc2373G>C rs4675379  Haimila et al., 2009b 
Table 2. All the published genetic association studies related to T cell co-stimulatory 
receptors listed according to the polymorphisms examined. 
Although genome-wide association studies are simple to conduct and commonly used in 
other complex trait studies, none have been carried out in organ transplantation. In a typical 
genome-wide association study, up to a million genetic markers covering a significant 
portion of the common variation are simultaneously tested. The two main characteristics of 
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genome wide studies are the large number of SNPs and the unbiased selection of these 
SNPs. Another approach, already demonstrated to be effective in bone marrow 
transplantation (McCarroll et al., 2009), is the systematic screening of gene deletions in the 
genome. Homozygous deletion of a gene in a recipient leads to immunological recognition 
of the encoded molecule if the graft can express the molecule. The results demonstrate that 
deletions are surprisingly common in our genome. 
4. Conclusions 
The identification of genetic factors that can modulate severity of acute rejection episodes 
may help to improve long-term graft survival. Functional variation in the gene regions of 
cytokines and/or T cell co-stimulatory receptors may affect the immune responsiveness of a 
graft recipient and thus, may predispose to the poor outcome of kidney transplantation. 
Technological advances in high-throughput genotyping methods would allow more intense 
genotyping of patients before transplantation. On the basis of genetic information, an 
amount of immunosuppressants could be set to a right level to avoid graft loss, on one 
hand, and undesired side effects of drugs, on the other hand. 
The genes of cytokines and T cell co-stimulatory receptors are highly interesting but the final 
evidence for their role in renal transplantation still remains to be found. Genetic risk may not 
be due to a polymorphism in a single gene but rather a few haplotypes carrying a pattern of 
variations that act together. The combinatory effect may allow classification of patients into 
low- and high-responders. The involvement of several polymorphisms as well as confounding 
non-genetic factors, in particular differences in immunosuppression would explain the 
conflicting association reports from different populations. Larger studies are, however, still 
required. Even more importantly, true disease risk variants must be confirmed by functional 
assays. In addition, implementation of genome-wide association studies is necessary. Besides 
SNPs, the effect of structural variants, such as insertion/deletion and copy number variations 
should also be scrutinized in organ transplantation. 
The major problem with genetic association studies is the small size of study populations 
(Hattersley & McCarthy, 2005). Although the sizes have increased in the more recent 
studies, the number of endpoint cases is still small and thus, the power of analysis is 
inadequate. The median rate of acute rejection was 18% in the recent multicentre study by 
Israni et al (2010). This means that thousands of patients need to be enrolled to the study 
before the number of acute rejection (or another endpoint) cases is sufficient for detecting 
the real underlying genetic variants, each of which may only have a weak individual effect.  
Despite improved immunosuppressive medicaments, new organ preservation techniques, 
and decreased rejection rates, the improvement in long-term kidney allograft survival has 
been modest. There is growing interest in immunogenetics: if genetic factors determining 
the level of the immune response are combined with knowledge on effects of gene variation 
on drug metabolism, more personalized immunosuppression regimes for the patients can be 
developed. 
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